ENTX
Entera Bio Ltd.
An Israeli biopharmaceutical company turning injections into once-daily pills. Entera Bio develops oral tablets of hormones like parathyroid hormone (PTH), aiming to treat conditions such as osteoporosis and hypoparathyroidism that normally require daily shots, using its proprietary N-Tab platform that helps fragile peptides survive digestion. Founded in 2009 by Phillip Schwartz and Zeev Bronfeld, it reportedly began as a two-person operation in the storage room of an apartment before growing into a NASDAQ-listed company.
ISIN: IL0011429839HealthcareIL1 holder
Total Value
$534.4K
Total Shares
233.4K
Net Share Change
-551.8K
Activity
1 selling
Investor
Value
Shares
Weight
Change
